期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (1)
Purpose The purposes of this study were to evaluate the current situation of pain management outcomes, patients' pain knowledge, and family caregivers......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (4)
Purpose While the existing knowledge base on the impact of prostate cancer (PC) and its treatment on sexuality and intimacy has been generated from We......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (5)
Purpose To determine the effect of various cleaning methods for skin with acute radiation dermatitis (RD) in patients treated for nasopharyngeal carci......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (5)
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of anticancer treatment based on neurotoxic agents, which may affect......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (7)
Objective A prospective randomized controlled trial was conducted to compare 5 mg olanzapine plus standard triple antiemetic therapy for the preventio......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (10)
Background and objectives The purpose of this study is to determine the risk of constipation and to identify the significant risk factors for constipa......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (3)
Objective Decreased quality of life (QoL) in thyroid cancer patients after thyroidectomy is a common, but there is a lack of predictive methods for de......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (10)
Purpose To quantify financial toxicity of female patients with breast cancer in China and investigate its factors and patients' coping strategies. Met......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (11)
Purpose The elevated physical symptom burden in advanced lung cancer can disrupt patients' emotional well-being, and current literature suggests that ......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (11)
Purpose Heated humidified high-flow nasal cannula (HFNC) oxygen therapy is one of the most important oxygen therapy methods, which are commonly applie......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (1)
Background Few mortality-scoring models are available for solid tumor patients who are predisposed to develop Escherichia coli-caused bloodstream infe......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (2)
Background Sarcopenia has been proved to be related to the prognosis of patients with bladder cancer (BC) after radical cystectomy (RC). The relations......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (5)
Background Obesity and weight gain have been associated with poor disease-specific and health-related outcomes in breast cancer survivors (BCS). But t......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (6)
Purpose The aim of this study was to investigate symptom clusters and associated clinical factors in ambulatory multiple myeloma patients undergoing m......
期刊： SUPPORTIVE CARE IN CANCER, 2022; 30 (7)
Purpose Axicabtagene ciloleucel (Axi-Cel, 2 x 10(6) CAR-T cells/kg, single intravenous injection) is a chimeric antigen receptor cell immunotherapy th......
